Written Question·Department of Health and Social Care·UIN 28288
Givinostat
Tabled: 3 February 2025
Answered: 10 February 2025
Question
Martin Wrigley
Liberal Democrat — Newton Abbot
To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to NHS Trusts on tackling administrative barriers to access to Givinostat treatment.
Answer
Karin SmythITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 28288) →
Partner sites